Metastatic SMARCB1-Deficient Renal Medullary Carcinoma without Hemoglobinopathy with Durable and Dramatic Response to Pembrolizumab plus Lenvatinib: Case Report.

Autor:	McCamy, William1 (AUTHOR) ehall2@fredhutch.org, Yousefiasl, Maryam1 (AUTHOR), Tretiakova, Maria2 (AUTHOR), Jagtiani, Minal3 (AUTHOR), Hall, Evan1,4 (AUTHOR)
Zdroj:	Case Reports in Oncology. Sep2024, Vol. 17 Issue 1, p1025-1033. 9p. 3 Illustrations.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu